International Journal of Clinical and Experimental Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2025-09-01 ms7000002977722171 来自上海

它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。
投稿时，研究得有新意，表述清晰准确，逻辑连贯。
稿件需符合规范格式，图表要清晰标注。
期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。

28 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-12-27 MS54455111222

期刊分类很多，如何选择合适的期刊？

212 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2023-12-03 ms8000001039313949 来自安徽省

现在这个杂志还算SCI吗？？？？？？

170 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2023-07-11 1258afaem06暂无昵称来自上海

esci 0.1

172 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-12-31 agile

偏重的研究方向：肿瘤
经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA

233 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2022-01-15 agile

偏重的研究方向：基础
经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com

224 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-12-27 Mia

选刊的流程是什么？

211 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-03-02 1247f785m03(暂无昵称)

今年的第一期第二期文章还会被收录吗？

251 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-02-24 yomier

原来发表的还能算sci吗？现在撤稿可以吗？

295 12 举报

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2279633, encodeId=b82722e96330d, content=它是月刊，专注临床医学与实验医学领域，涵盖内科、外科、妇产科、儿科、传染病学、生理学、药理学等医学相关科目。 投稿时，研究得有新意，表述清晰准确，逻辑连贯。 稿件需符合规范格式，图表要清晰标注。 期刊一般邀请至少2位审稿人，审稿周期约3个月，接收率在 50% 左右。录用后涉及版面费，具体金额和支付方式会有说明。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms7000002977722171, createdTime=Mon Sep 01 22:25:22 CST 2025, time=2025-09-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1105811, encodeId=a2c111058119c, content=期刊分类很多，如何选择合适的期刊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172628, encodeId=8be221e26281f, content=现在这个杂志还算SCI吗？？？？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=53128143603, createdName=ms8000001039313949, createdTime=Sun Dec 03 10:31:42 CST 2023, time=2023-12-03, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2147403, encodeId=0fd5214e40302, content=esci 0.1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/22/8934a036b8657bc6de4ad28db345518d.jpg, createdBy=7bd02573507, createdName=1258afaem06暂无昵称, createdTime=Tue Jul 11 06:37:09 CST 2023, time=2023-07-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1179233, encodeId=05e311e923329, content=偏重的研究方向：肿瘤 经验分享：2021年《国际期刊预警名单（试行）》正式发布。 International Journal of Clinical and Experimental Medicine (IJCEM)已不在该预警名单中。具体内容请参照https://mp.weixin.qq.com/s/dEIsgG3tCZRoWQBZ8UEJQA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Fri Dec 31 12:04:23 CST 2021, time=2021-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184568, encodeId=9a23118456859, content=偏重的研究方向：基础 经验分享：IJCEM 2021年所有文章都可以在Web of Science里检索到了: www.IJCEM.com, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e982088871, createdName=agile, createdTime=Sat Jan 15 13:06:18 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105812, encodeId=562711058127f, content=选刊的流程是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944703, encodeId=090d944e0366, content=今年的第一期第二期文章还会被收录吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0e2492369, createdName=1247f785m03(暂无昵称), createdTime=Tue Mar 02 11:16:07 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926855, encodeId=cec9926855f3, content=原来发表的还能算sci吗？现在撤稿可以吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmhead/PFPUMLY8F75pRwuLlmSND8Dgr88kVg993qE5ecvfNqxwtzzYGvJGkQ/0, createdBy=b6402054570, createdName=yomier, createdTime=Wed Feb 24 14:10:24 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063229, encodeId=61e7106322927, content=偏重的研究方向：Meta 经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8db61976017, createdName=猫星云, createdTime=Sat Oct 23 20:22:43 CST 2021, time=2021-10-23, status=1, ipAttribution=)]

2021-10-23 猫星云

偏重的研究方向：Meta
经验分享：这个期刊查重率要求多少？是不是对每个稿件都会查重才刊登？

221 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务